The agenda for the 1 April 2015 TC meeting is now available. The Commission will consider the following technologies:

• Temocillin sodium (Negaban) - new medicine
• Ondansetron (Setofilm) - review of SMR & ASMR
• Pasireotide diaspartate (Signifor) - new indication

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2015-03/odj_ct_01042015_internet.pdf [French]